Archive for February, 2010
« Previous EntriesStatin therapy benefits diabetes patients with CHD, but normal cholesterol
Wednesday, February 24th, 2010Source: MedWire News
Study results show that diabetic patients with coronary heart disease (CHD), but normal cholesterol levels, benefit more from standard-dose statin therapy than nondiabetics with CHD.
“Diabetic patients have as high a risk of first myocardial infarction (MI) as nondiabetic patients with a previous MI,” say Sunao Kojima (Kumamoto University, Japan) and colleagues.
“Therefore, medical treatment […]
Simplified Darunavir Therapy Successful in Experienced Patients
Tuesday, February 23rd, 2010Once-daily dosing of the protease inhibitor darunavir (Prezista) appeared to be at least as effective as twice-a-day regimens among treatment-experienced patients with no darunavir-associated resistance mutations, researchers reported here.
Study subjects received an optimized nucleoside backbone regimen and were randomized to either once- or twice-daily darunavir boosted with ritonavir.
Some 72.1% achieved undetectable HIV viral load on […]
High-fiber diet linked to reduced risk for COPD
Tuesday, February 23rd, 2010Source: MedWire News
A diet high in fiber, particularly from cereals, is associated with a reduced risk for chronic obstructive pulmonary disease (COPD), researchers have found.
Previous studies have suggested that, in addition to smoking, general diet may also be associated with COPD risk. Indeed, a western-style diet, which is high in cured and red meats, […]
Analysis examines finasteride treatment recommendations.
Friday, February 19th, 2010Medscape (2/11, Nelson) reported that although finasteride (Proscar) appeared to reduce the risk of prostate cancer “by nearly 25%…in men 55 years and older,” a new paper appearing in the Journal of Clinical Oncology says that the finding doesn’t address the issue of “who to recommend the drug to.” According to Memorial Sloan-Kettering Cancer Center […]
Statins pre-surgery may hinder advancement of prostate cancer
Friday, February 19th, 2010Source: MedWire News
Research shows that prostate cancer patients who use statins before undergoing radical prostatectomy (RP) are at significantly lower risk for tumor inflammation than men who do not take statins pre-surgery.
Previous research has indicated that inflammation is associated with advanced prostate cancer, and statin use has been associated with a decreased risk for prostate […]
